02/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/09/2024

Sep 2, 2024, 17:43 | Blog
Bernard A. Fox: First time for me to participate in this type of satellite program, but it won’t be my last!
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “What a great evening…
Sep 2, 2024, 17:36 | Blog
Society of Surgical Oncology - Apply for the first ever International Career Development Exchange
Society of Surgical Oncology shared on X: "Reminder to apply for the first ever International Career…
Sep 2, 2024, 17:34 | Blog
Elisabetta Bonzano: Improved efficacy outcomes in early-stage TNBC neoadjuvant ICI therapy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Neoadjuvant Immune Checkpoint…
Sep 2, 2024, 17:31 | Blog
The Global Coalition for Radiotherapy - An RT treatment system for challenging environments
The Global Coalition for Radiotherapy shared on X: "RADIOTHERAPY NEWS  The Smart Technologies to Extend Lives…
Sep 2, 2024, 17:29 | Blog
Michael Chuong: Letter to editor regarding 1.5 T MRL pancreas planning protocol manuscript
Michael Chuong, Lead GI Radiation Oncologist at Miami Cancer Institute, shared on X: "Letter to editor…
Sep 2, 2024, 17:27 | Positive
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Starting from August 26th, Women’s Equality Day in the United States—a day celebrating the 1920…
Sep 2, 2024, 17:26 | Blog
Kimryn Rathmell: Check out NCI’s Cancer Currents blog
Kimryn Rathmell shared on X: "If you’re looking for news about advances in Cancer Research and…
Sep 2, 2024, 17:24 | Insight
Oncology experts' perceptions on integrative medicine
MASCC shared a post on X: "New open-access article in MASCC JSCC: Oncology researchers’ and clinicians’…
Sep 2, 2024, 17:22 | Insight
Carmine Valenza: The role of gBRCA-PV in post-PARPi myeloid neoplasms, in patients with ovarian cancer
Carmine Valenza, MPH Student at Harvard T.H. Chan School of Public Health, shared a post…
Sep 2, 2024, 17:17 | Insight
Jarushka Naidoo: Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
Jarushka Naidoo shared a post on X: "Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early…
All: 98 Posts: 11 - 20
Special Coverage